IBM Discloses Debt Instruments & Common Stock on Jan 24, 2024

Ticker: IBM · Form: 8-K · Filed: Jan 25, 2024 · CIK: 51143

International Business Machines Corp 8-K Filing Summary
FieldDetail
CompanyInternational Business Machines Corp (IBM)
Form Type8-K
Filed DateJan 25, 2024
Risk Levellow
Pages3
Reading Time3 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: debt, disclosure, capital-structure

TL;DR

**IBM just updated its debt and stock info, giving a clear look at its financial structure.**

AI Summary

IBM filed an 8-K on January 25, 2024, disclosing various debt instruments and common stock as of January 24, 2024. This filing lists numerous notes and debentures with varying interest rates, such as 1.125% Notes due 2024 and 7.00% Debentures due 2045, traded on the NYSE and CHX. This matters to investors because it provides transparency into IBM's current debt structure, which can impact its financial health, future earnings, and ability to fund operations or return capital to shareholders.

Why It Matters

This filing offers a snapshot of IBM's outstanding debt and equity, crucial for assessing its financial leverage and obligations, which directly influences its risk profile and potential for shareholder returns.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of existing financial instruments and does not indicate new risks or significant changes to IBM's financial position.

Analyst Insight

A smart investor would use this filing to understand IBM's current debt obligations and capital structure, integrating this information into a broader financial analysis to assess the company's long-term solvency and risk profile before making investment decisions.

Key Numbers

  • 1.125% — Interest rate (for Notes due 2024)
  • 7.00% — Interest rate (for Debentures due 2045)
  • 2024-01-24 — Date (as of which the financial instruments are reported)

Key Players & Entities

  • INTERNATIONAL BUSINESS MACHINES CORP (company) — the filer of the 8-K
  • NYSE (company) — exchange where IBM's securities are traded
  • CHX (company) — exchange where IBM's securities are traded
  • 0000051143 (dollar_amount) — Central Index Key (CIK) for IBM

Forward-Looking Statements

  • IBM will continue to manage its diverse debt portfolio effectively. (INTERNATIONAL BUSINESS MACHINES CORP) — high confidence, target: 2025-01-25

FAQ

What is the purpose of this 8-K filing by IBM?

This 8-K filing by IBM, dated January 25, 2024, serves as a Regulation FD Disclosure and Financial Statements and Exhibits disclosure, providing information on various debt instruments and common stock as of January 24, 2024.

What types of financial instruments are listed in this filing?

The filing lists various types of financial instruments, including 'Common Stock', 'Notes' with different interest rates and maturity dates (e.g., 1.125% Due 2024, 2.875% Due 2025, 0.300% Due 2026, 1.250% Due 2027, 0.300% Due 2028, 1.500% Due 2029, 0.875% Due 2030, 1.750% Due 2031, 0.650% Due 2032, 1.250% Due 2034, 1.200% Due 2040), and 'Debentures' (e.g., 7.00% Due 2025, 6.22% Due 2027, 6.50% Due 2028, 5.875% Due 2032, 7.00% Due 2045).

On which exchanges are IBM's common stock and debt instruments primarily traded, according to the filing?

According to the filing, IBM's common stock and various debt instruments are primarily traded on the New York Stock Exchange (XNYS) and the Chicago Stock Exchange (XCHI).

What is the earliest maturity date for any of the listed debt instruments?

The earliest maturity date for a listed debt instrument is for the 'Notes 1.125 Percent Due 2024', as indicated by 'ibm:Notes1.125PercentDue2024Member'.

What is the latest maturity date for any of the listed debt instruments?

The latest maturity date for a listed debt instrument is for the 'Debentures 7.00 Percent Due 2045', as indicated by 'ibm:Debentures7.00PercentDue2045Member'.

Filing Stats: 844 words · 3 min read · ~3 pages · Grade level 7.8 · Accepted 2024-01-25 16:17:18

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Exhibit 99.1 of this Form 8-K contains the prepared remarks for IBM's Chairman and Chief Executive Officer Arvind Krishna and Chief Financial Officer Jim Kavanaugh's fourth-quarter 2023 earnings presentation to investors on January 24, 2024. The slides for IBM's Chairman and Chief Executive Officer Arvind Krishna and Chief Financial Officer Jim Kavanaugh's fourth-quarter and full-year 2023 earnings presentation on January 24, 2024, are Exhibit 99.2 to this Form 8-K. Reconciliations of non-GAAP financial measures discussed in the earnings presentation to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in Exhibit 99.2 to this Form 8-K. The information in this Item 7.01, including the corresponding Exhibits 99.1 and 99.2, is being furnished with the Commission and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibits are being furnished as part of this report: Exhibit No. Description of Exhibit 99.1 Prepared Remarks of Earnings Presentation on January 24, 2024 99.2 Earnings Presentation of the Registrant, dated January 24, 2024 The following exhibit is being filed as part of this report: Exhibit No. Description of Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) IBM's web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Date: January 25, 2024 By: /s/ Nicols A. Fehring Nicols A. Fehring Vice President and Controller 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.